Royalty Pharma Plc (RPRX)
49.65
+0.27
(+0.55%)
USD |
NASDAQ |
Apr 27, 16:00
49.20
-0.45
(-0.91%)
After-Hours: 20:00
Royalty Pharma Profit Margin (Quarterly) : 57.23% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Zymeworks, Inc. | -1.64K% |
| Johnson & Johnson | 21.75% |
| Revolution Medicines, Inc. | -- |
| Corcept Therapeutics, Inc. | 11.83% |
| Cytokinetics, Inc. | -1.03K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 13.52% |
| Return on Assets | 7.11% |
| Return on Invested Capital | 7.34% |
| Gross Profit Margin (Quarterly) | 99.81% |
| Operating Margin (Quarterly) | 62.38% |
| Return on Net Operating Assets | 7.86% |